Citigroup
ARMP icon

Citigroup’s Armata Pharmaceuticals ARMP Stock Holding History

Citigroup’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3K Buy
5,603
+443
+9% +$4.06K ﹤0.01% 5053
2026
Q1 		$52.8K Buy
+5,160
New +$43.4K ﹤0.01% 4506
2019
Q2 		– Sell
-1
Closed – – 7730
2019
Q1 		$0 Hold
1
– – ﹤0.01% 7646
2018
Q4 		$0 Hold
1
– – ﹤0.01% 7656
2018
Q3 		$0 Hold
1
– – ﹤0.01% 7734
2018
Q2 		$0 Hold
1
– – ﹤0.01% 7594
2018
Q1 		$0 Hold
1
– – ﹤0.01% 7525
2017
Q4 		$0 Hold
1
– – ﹤0.01% 7545
2017
Q3 		$0 Buy
+1
New +$13 ﹤0.01% 7244
2015
Q4 		– Sell
-11
Closed -$6K – 7529
2015
Q3 		$6K Buy
+11
New +$10.1K ﹤0.01% 6634

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Citigroup's ARMP Position: Q2 2026 in Review

Citigroup increased its Armata Pharmaceuticals (ARMP) stake by 8.6% in Q2 2026, buying an estimated $4.06K and bringing the position to 5,603 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5053.

Citigroup first reported a position in ARMP in Q3 2015 and has held it in 10 quarters since. The position peaked at $52.8K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Citigroup held 5,603 shares of Armata Pharmaceuticals worth $36.3K as of Q2 2026.
  • Citigroup bought 443 Armata Pharmaceuticals shares in Q2 2026, an estimated $4.06K.
  • Armata Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5053 holding.
  • Citigroup first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 10 quarters since.
  • Citigroup's Armata Pharmaceuticals position peaked at $52.8K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.